We are live on
!
Find out more
PAMS
Pictet Asset Management (Switzerland) Portfolio holdings
AUM
$84.3B
1-Year Est. Return
26.5%
This Fund
S&P 500
This Quarter
Est. Return
-2.87%
1 Year Est. Return
+26.5%
3 Year Est. Return
–
5 Year Est. Return
–
10 Year Est. Return
–
AUM
$67.4B
AUM Growth
-$4.5B
(-6.3%)
Cap. Flow
-$1.33B
Cap. Flow
% of AUM
-1.98%
Top 10 Holdings %
Top 10 Hldgs %
15.02%
Holding
1,643
New
69
Increased
632
Reduced
516
Closed
78
Top Buys
| Rank | Stock | Value |
|---|---|---|
| 1 |
Weyerhaeuser
WY
|
+$156M |
| 2 |
Amazon
AMZN
|
+$104M |
| 3 |
LSI
Life Storage, Inc.
LSI
|
+$79.1M |
| 4 |
Eversource Energy
ES
|
+$73.2M |
| 5 |
Exelon
EXC
|
+$67.7M |
Top Sells
| Rank | Stock | Value |
|---|---|---|
| 1 |
ZEN
ZENDESK INC
ZEN
|
+$159M |
| 2 |
Meta Platforms (Facebook)
META
|
+$120M |
| 3 |
Avantor
AVTR
|
+$108M |
| 4 |
Alphabet (Google) Class C
GOOG
|
+$99.1M |
| 5 |
CCXI
ChemoCentryx, Inc.
CCXI
|
+$97.9M |
Sector Composition
| Rank | Sector | Weight |
|---|---|---|
| 1 | Technology | 25.43% |
| 2 | Healthcare | 16.31% |
| 3 | Industrials | 15.57% |
| 4 | Utilities | 11.18% |
| 5 | Consumer Discretionary | 8.31% |
| Name | Market Value | Portfolio Weight | Shares or Principal |
Change in Stake | Capital Flow | |
|---|---|---|---|---|---|---|
451
Qualys
QLYS
$6.54B
| $18.4M | 0.03% |
131,784
-18,199
| -12% | -$2.56M |
|
452
Kinder Morgan
KMI
$70.9B
| $18.4M | 0.03% |
1,103,595
+81,382
| +8% | +$1.45M |
|
453
Constellation Brands
STZ
$23.2B
| $18.3M | 0.03% |
79,890
-2,037
| -2% | -$496K |
|
454
Nutrien
NTR
$32B
| $18.2M | 0.03% |
216,640
-176
| -0.1% | -$15.1K |
|
455
Manulife Financial
MFC
$72.6B
| $18.1M | 0.03% |
1,147,265
+426,087
| +59% | +$7.47M |
|
456
Alexandria Real Estate Equities
ARE
$8.31B
| $18M | 0.03% |
128,533
+9,913
| +8% | +$1.52M |
|
457
Canadian Natural Resources
CNQ
$97.8B
| $17.8M | 0.03% |
761,786
-11,381
| -1% | -$295K |
|
458
American International
AIG
$39.7B
| $17.8M | 0.03% |
374,588
-10,654
| -3% | -$560K |
|
459
Consolidated Edison
ED
$39.9B
| $17.7M | 0.03% |
205,931
+11,218
| +6% | +$1.08M |
|
460
Insulet
PODD
$10B
| $17.5M | 0.03% |
76,294
+31,749
| +71% | +$7.95M |
|
461
Motorola Solutions
MSI
$76.5B
| $17.4M | 0.03% |
77,698
+279
| +0.4% | +$65.8K |
|
462
Monster Beverage
MNST
$91.8B
| $17.3M | 0.03% |
793,680
-6,184
| -0.8% | -$142K |
|
463
iShares Gold Trust
IAU
$64.6B
| $17.1M | 0.03% |
541,930
-285,780
| -35% | -$9.37M |
|
464
State Street
STT
$52.1B
| $17M | 0.03% |
279,873
-4,924
| -2% | -$337K |
|
|
MRTX
465
DELISTED
Mirati Therapeutics, Inc. Common Stock
MRTX
| $16.8M | 0.03% |
240,980
+2,033
| +0.9% | +$150K |
|
466
Arthur J. Gallagher & Co
AJG
$64.3B
| $16.6M | 0.02% |
97,220
+532
| +0.6% | +$94.4K |
|
467
Bright Horizons
BFAM
$3.78B
| $16.6M | 0.02% |
287,959
+4,244
| +1% | +$323K |
|
468
iShares Global Utilities ETF
JXI
$307M
| $16.5M | 0.02% |
300,446
-191,482
| -39% | -$11.8M |
|
469
Corteva
CTVA
$50.2B
| $16.3M | 0.02% |
285,366
-3,503
| -1% | -$204K |
|
470
Keurig Dr Pepper
KDP
$42.1B
| $16.1M | 0.02% |
450,115
-1,901
| -0.4% | -$71.9K |
|
471
iShares iBoxx $ Investment Grade Corporate Bond ETF
LQD
$32.8B
| $16M | 0.02% |
156,363
-50,402
| -24% | -$5.56M |
|
472
Amphenol
APH
$210B
| $16M | 0.02% |
478,348
-6,968
| -1% | -$253K |
|
473
Waters Corp
WAT
$40.9B
| $15.9M | 0.02% |
59,138
-1,019
| -2% | -$325K |
|
|
PYCR
474
DELISTED
Paycor HCM, Inc. Common Stock
PYCR
| $15.9M | 0.02% |
538,847
-359,193
| -40% | -$10.4M |
|
475
Newmont
NEM
$120B
| $15.9M | 0.02% |
377,133
-2,571
| -0.7% | -$120K |
|
Similar funds
TF
TAIM
V
PI
WI
VIA
EST
TCM
Pictet Asset Management (Switzerland)'s Q3 2022 Portfolio in Review
As of Q3 2022, Pictet Asset Management (Switzerland) held 1,643 positions worth $67.4B, down 6.3% from $71.9B the previous quarter. Its ten largest holdings account for 15% of the portfolio.
Pictet Asset Management (Switzerland)'s Q3 2022 filing shows 69 new, 632 increased, 516 reduced and 78 closed positions. Its largest new stake was Ventyx Biosciences: 1,071,983 shares worth $37.4M. The largest sale was ZENDESK INC, an estimated $159M.
By sector, the portfolio is most concentrated in Technology at 25% of assets, down from 26% a quarter earlier, followed by Healthcare and Industrials.
- Pictet Asset Management (Switzerland)'s largest Q3 2022 buy was Ventyx Biosciences: 1,071,983 shares worth $37.4M.
- Pictet Asset Management (Switzerland) added most to Weyerhaeuser in Q3 2022, an estimated $156M increase.
- Pictet Asset Management (Switzerland)'s biggest Q3 2022 reduction was ZENDESK INC, cutting an estimated $159M.
- Pictet Asset Management (Switzerland) fully exited Biohaven Pharmaceutical Holding Company Ltd. in Q3 2022, selling an estimated $32M.
- Pictet Asset Management (Switzerland)'s ten largest holdings make up 15% of its $67.4B portfolio in Q3 2022.
- Pictet Asset Management (Switzerland) opened 69 new positions and closed 78 in Q3 2022.
- Pictet Asset Management (Switzerland)'s portfolio value fell 6.3% quarter-over-quarter to $67.4B.
Based on Pictet Asset Management (Switzerland)'s 13F filing for Q3 2022, filed 14 Nov 2022.